X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33925) 33925
Publication (2522) 2522
Newspaper Article (1507) 1507
Book Review (442) 442
Magazine Article (279) 279
Newsletter (246) 246
Book / eBook (169) 169
Trade Publication Article (91) 91
Book Chapter (76) 76
Conference Proceeding (36) 36
Web Resource (27) 27
Report (18) 18
Transcript (18) 18
Dissertation (15) 15
Data Set (9) 9
Streaming Video (2) 2
Government Document (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22325) 22325
male (15577) 15577
female (14480) 14480
index medicus (13769) 13769
animals (9964) 9964
dexamethasone - administration & dosage (9208) 9208
middle aged (8981) 8981
adult (8487) 8487
dexamethasone (8297) 8297
aged (6772) 6772
oncology (6463) 6463
dose-response relationship, drug (6277) 6277
treatment outcome (5464) 5464
dosage and administration (4809) 4809
hematology (4050) 4050
rats (3985) 3985
chemotherapy (3919) 3919
antineoplastic combined chemotherapy protocols - therapeutic use (3918) 3918
dexamethasone - pharmacology (3807) 3807
research (3784) 3784
drug dosages (3698) 3698
care and treatment (3581) 3581
pharmacology & pharmacy (3570) 3570
drug therapy (3374) 3374
mice (3228) 3228
multiple myeloma (3124) 3124
cancer (2940) 2940
glucocorticoids - administration & dosage (2930) 2930
dexamethasone - therapeutic use (2870) 2870
time factors (2772) 2772
therapy (2764) 2764
health aspects (2555) 2555
adolescent (2458) 2458
corticosteroids (2454) 2454
multiple myeloma - drug therapy (2187) 2187
steroids (2096) 2096
risk factors (2090) 2090
aged, 80 and over (2049) 2049
patients (2018) 2018
retrospective studies (1955) 1955
antineoplastic combined chemotherapy protocols - adverse effects (1915) 1915
surgery (1910) 1910
drug therapy, combination (1888) 1888
drug administration schedule (1866) 1866
child (1864) 1864
analysis (1862) 1862
anti-inflammatory agents - administration & dosage (1840) 1840
clinical trials (1825) 1825
complications and side effects (1813) 1813
medicine (1808) 1808
prospective studies (1784) 1784
follow-up studies (1726) 1726
bortezomib (1721) 1721
immunology (1707) 1707
inflammation (1652) 1652
expression (1649) 1649
pediatrics (1641) 1641
studies (1617) 1617
cells, cultured (1610) 1610
dexamethasone - adverse effects (1582) 1582
research article (1570) 1570
ophthalmology (1551) 1551
glucocorticoids (1543) 1543
diagnosis (1519) 1519
pregnancy (1492) 1492
antineoplastic combined chemotherapy protocols - administration & dosage (1484) 1484
endocrinology & metabolism (1464) 1464
transplantation (1392) 1392
double-blind method (1390) 1390
medicine, general & internal (1382) 1382
prognosis (1376) 1376
prevention (1353) 1353
disease models, animal (1343) 1343
child, preschool (1304) 1304
administration, oral (1292) 1292
usage (1277) 1277
cyclophosphamide - administration & dosage (1271) 1271
young adult (1268) 1268
children (1254) 1254
survival (1245) 1245
medicine & public health (1242) 1242
double-blind (1238) 1238
glucocorticoids - pharmacology (1213) 1213
patient outcomes (1210) 1210
trial (1199) 1199
combined modality therapy (1196) 1196
apoptosis (1191) 1191
physiological aspects (1188) 1188
doxorubicin - administration & dosage (1160) 1160
rats, sprague-dawley (1159) 1159
stem cells (1154) 1154
disease (1147) 1147
disease-free survival (1144) 1144
stem-cell transplantation (1144) 1144
antineoplastic agents - adverse effects (1138) 1138
antineoplastic agents - administration & dosage (1133) 1133
recurrence (1106) 1106
drugs (1105) 1105
abridged index medicus (1090) 1090
cells (1090) 1090
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (108) 108
Collection Dvlpm't (Acquisitions) - Closed Orders (15) 15
Online Resources - Online (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - Hospital Department (2) 2
UTL at Downsview - May be requested (2) 2
Chemistry (A D Allen) - Reference (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Reference (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Pathology (1) 1
Mt Sinai Hospital - Stacks (1) 1
Pharmacy (1) 1
Scarborough Hospital - General (1) 1
UofT at Mississauga - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35331) 35331
German (268) 268
Russian (169) 169
French (161) 161
Spanish (101) 101
Polish (60) 60
Chinese (40) 40
Czech (33) 33
Japanese (22) 22
Portuguese (21) 21
Hungarian (18) 18
Italian (18) 18
Dutch (15) 15
Swedish (10) 10
Turkish (10) 10
Korean (9) 9
Danish (7) 7
Romanian (7) 7
Bulgarian (5) 5
Croatian (5) 5
Serbian (5) 5
Ukrainian (5) 5
Hebrew (4) 4
Arabic (2) 2
Bosnian (2) 2
Finnish (2) 2
Norwegian (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article
Cancer, ISSN 0008-543X, 02/2006, Volume 106, Issue 4, pp. 848 - 858
BACKGROUND. Pegylated liposomal doxorubicin has pharmacologic and safety advantages over conventional doxorubicin. METHODS. For this noninteriority trial, 192... 
Dexamethasone | Neutropenic fever | Drug toxicity | Multiple myeloma | Liposomes | Drug resistance | Doxorubicin | Pegylated liposomal doxorubicin | Vincristine | Neoplasms | dexamethasone | 1ST-LINE TREATMENT | multiple myeloma | vincristine | ONCOLOGY-GROUP | liposomes | COMBINATION THERAPY | neutropenic fever | CONVENTIONAL DOXORUBICIN | TRANSPLANTATION | pegylated liposomal doxorubicin | THALIDOMIDE PLUS DEXAMETHASONE | KAPOSIS-SARCOMA | ONCOLOGY | drug toxicity | REDUCED-DOSE DEXAMETHASONE | VAD | doxorubicin | drug resistance | neoplasms | DVD-T | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Polyethylene Glycols - adverse effects | Male | Fever - chemically induced | Multiple Myeloma - drug therapy | Doxorubicin - analogs & derivatives | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Administration, Oral | Catheterization, Central Venous | Treatment Outcome | Polyethylene Glycols - administration & dosage | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Infusions, Intravenous | Doxorubicin - adverse effects | Pharmaceutical research | Drugs | Myelocytic leukemia | Reports | Nonlymphoid leukemia | Research | Drug therapy, Combination | Drug therapy | Health aspects
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10068, pp. 519 - 527
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1055 - 1066
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1621 - 1634
The addition of the oral proteasome inhibitor ixazomib to a regimen of lenalidomide plus dexamethasone led to a significant prolongation of progression-free... 
SUPERIORITY | MEDICINE, GENERAL & INTERNAL | CARFILZOMIB | RANDOMIZED PHASE-3 | THERAPY | PROTEASOME INHIBITOR MLN9708 | QUALITY-OF-LIFE | BORTEZOMIB | THALIDOMIDE | ANTITUMOR-ACTIVITY | TRANSPLANTATION | Glycine - analogs & derivatives | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Boron Compounds - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Exanthema - chemically induced | Aged, 80 and over | Adult | Glycine - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Administration, Oral | Kaplan-Meier Estimate | Proportional Hazards Models | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Boron Compounds - adverse effects | Aged | Care and treatment | Dosage and administration | Dexamethasone | Multiple myeloma | Thrombocytopenia | Inhibitor drugs | Risk groups | Drug therapy | Peripheral neuropathy | Survival | Patients | Drug dosages | Proteasome inhibitors | Quality of life | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Journal Article